MyopiaX® is a smartphone application that provides a treatment to slow the progression of myopia in children and adolescents. We are conducting a clinical trial (NCT04967287) to investigate the safety and efficacy of MyopiaX® to control the progression of myopia. Used in combination with a virtual reality headset and wireless controller, the MyopiaX® app is designed to provide and achieve a medical treatment. Intended to be used twice a day, each session with MyopiaX® is several minutes long and delivers our patented, light-based technology treatment with a child-friendly virtual reality game.
The MyopiaX® clinical trial is including…
The study has been reviewed and approved to be conducted by the regulatory authorities and ethics committees of the respective clinical institutions in each country to ensure participants’ safety and well-being throughout the trial.
For more information, contact us at firstname.lastname@example.org or get in touch with a research specialist from one of the clinics below. Researchers and clinicians are also welcome to use this e-mail address to reach out to us with questions or for more information.
Centre for Eye Research Ireland
Dr. Matilda Biba
Erasmus University Medical Center
Trialbureau Oogheelkunde Erasmus MC
+31 10 7039740
University of Minho
+351 253 604 324
University Complutense of Madrid
Ocupharm Research Group
+34 611 63 84 34